Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2000; 7(2): 141-143


Epstein-barr and cytomegalovirus antibody positivities in inflammatory rheumatic diseases

 

Yüksel ERSOY*,  Yasemin ERSOY**, Barış OTLU***, İrfan KARATUTLU*,  Zühal ALTAY*,  Emine SÖNMEZ**, İ.Halil ÖZEROL***

.




Abstract


 


Objectives: Studies on the role of viruses on pathogenesis of the inflammatory rheumatic diseases for which autoimmune mechanisms have been believed to those play important roles, still have increased popularity. This study has been conducted to explore EBV-VCA and CMV antibody positivities in serum samples of patients with inflammatory rheumatic diseases such as RA and AS.

Material and methods: The patients with RA (n=38) and AS (n=36) who admitted to outpatient clinics of the department of PM&R and 41 healthy volunteers were been included in this study. Serum EBV-VCA IgG and EBV-VCA IgM, and CMV IgG, IgM, and IgA antibodies were measured by ELISA as positive or negative results.

Results: CMV IgA antibody positivities in patients with RA were higher than the control group; in addition EBV-VCA IgM antibody positivities were higher in the patients with RA than those with AS and healthy volunteers.

Conclusion: These results suggest that EBV infections may play a role in etiopathogenesis of RA.

Key words: Inflammatory rheumatic disease, Epstein-Barr Virus, Cytomegalovirus, EBV, CMV.








Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.